Alvogen Inc. filed a new generic application (ANDA206986) for oral hydrocodone bitartrate on January 21, 2020. This approval is expected to intensify ...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Granules Pharmaceuticals Inc. announced the FDA approval of its ANDA for Hydrocodone Bitartrate and Acetaminophen, granting the company a strategic en...
# FDA Approves Daiichi Sankyo's ENHERTU for HER2-Positive Cancers The FDA has approved Daiichi Sankyo Inc.'s ENHERTU (fam-trastuzumab deruxtecan-nxki...
The U.S. FDA has approved the INDICATION for Enfortumab Vedotin (Padcev EJFV) for INITIATED TREATMENT of LOCALIZED MUSCOSAL SQUAMOUS CELL CARCINOMA (U...
Concord Biotech Limited announced the FDA approval of its ANDA for Mycophenolate Sodium Oral Suspension, providing a crucial oral bioequivalent to Myc...
# FDA Approves Vigabatrin Generic from Cipla USA Cipla USA, Inc. received FDA approval for its generic vigabatrin oral formulation, expanding the com...
Shionogi Inc. announced the FDA approval of FETROJA (cefiderocol sulfate tosylate) Intravenous injection for the treatment of certain hospital-acquire...
Sun Pharmaceutical Industries, Inc. secured FDA approval for oral isotretinoin brand Absorica LD, positioning the Indian pharma giant to capture signi...
Sandoz Inc. has secured FDA approval for the biosimilar PEGFILGRASTIM-BMEZ (ZIEXTENZO), filling a major void in the market for a subcutaneous granuloc...
The U.S. FDA has approved oral palbociclib (IBRANCE, NDA212436) manufactured by U.S. Pharmaceuticals, a move that broadens the accessibility of this w...
ScieGen Pharmaceuticals, Inc. has received FDA approval for its Abbreviated New Drug Application for Naproxen Sodium, launching an additional generic ...
# FDA Approves Vertex Pharmaceuticals' TRIKAFTA for Cystic Fibrosis Vertex Pharmaceuticals Incorporated announced FDA approval of TRIKAFTA (elexacaft...
# FDA Approves ANI Pharmaceuticals' Generic Acetazolamide ANI Pharmaceuticals, Inc. received FDA approval for its generic acetazolamide oral formulat...
Gland Pharma Limited announced that the FDA has approved the ANDA for Neostigmine Methylsulfate, a cholinesterase inhibitor indicated for the reversal...
Cranbury Pharmaceuticals, LLC received FDA approval on October 7, 2019, for Doxycycline Hyclate oral tablets, expected to increase generic supply and ...
Upsher-Smith Laboratories announced on September 23, 2019, that the Food and Drug Administration had approved its generic testosterone formulation for...
Ajanta Pharma USA Inc. received FDA approval on September 13, 2019, for the oral generic of doxepin hydrochloride. The approval is expected to impact ...
Elite Laboratories, Inc. secured FDA approval for its generic Acetaminophen and Codeine Phosphate tablets (ANDA 212418), opening a pathway to capture ...
Novadoz Pharmaceuticals received FDA approval on Friday for the generic version of the antiemetic Fosaprepitant dimeglumine (ANDA209965), signaling fu...
BE Pharmaceuticals Inc. received U.S. approval for the intravenous formulation of fosaprepitant dimeglumine, positioning the company to compete in the...